Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors.
Saved in:
| Title: | Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors. |
|---|---|
| Authors: | Crawford MC; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA., Tripu DR; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA., Barritt SA; Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Jing Y; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA., Gallimore D; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA., Kales SC; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Bhanu NV; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA., Xiong Y; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA., Fang Y; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Butler KAT; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., LeClair CA; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Coussens NP; Molecular Pharmacology Laboratories, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Simeonov A; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA., Garcia BA; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA., Dibble CC; Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Meier JL; Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2023 May 16. Date of Electronic Publication: 2023 May 16. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37292747 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Crawford+MC%22">Crawford MC</searchLink>; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tripu+DR%22">Tripu DR</searchLink>; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Barritt+SA%22">Barritt SA</searchLink>; Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jing+Y%22">Jing Y</searchLink>; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gallimore+D%22">Gallimore D</searchLink>; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kales+SC%22">Kales SC</searchLink>; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bhanu+NV%22">Bhanu NV</searchLink>; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Xiong+Y%22">Xiong Y</searchLink>; Chemical Biology Laboratory, National Cancer Institute, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fang+Y%22">Fang Y</searchLink>; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Butler+KAT%22">Butler KAT</searchLink>; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22LeClair+CA%22">LeClair CA</searchLink>; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Coussens+NP%22">Coussens NP</searchLink>; Molecular Pharmacology Laboratories, Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.<br /><searchLink fieldCode="AU" term="%22Simeonov+A%22">Simeonov A</searchLink>; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Garcia+BA%22">Garcia BA</searchLink>; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Dibble+CC%22">Dibble CC</searchLink>; Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Meier+JL%22">Meier JL</searchLink>; Department of Pathology, Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2023 May 16. <i>Date of Electronic Publication: </i>2023 May 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Preprint; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37292747 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2023.05.15.540887 Languages: – Code: eng Text: English Titles: – TitleFull: Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Crawford MC – PersonEntity: Name: NameFull: Tripu DR – PersonEntity: Name: NameFull: Barritt SA – PersonEntity: Name: NameFull: Jing Y – PersonEntity: Name: NameFull: Gallimore D – PersonEntity: Name: NameFull: Kales SC – PersonEntity: Name: NameFull: Bhanu NV – PersonEntity: Name: NameFull: Xiong Y – PersonEntity: Name: NameFull: Fang Y – PersonEntity: Name: NameFull: Butler KAT – PersonEntity: Name: NameFull: LeClair CA – PersonEntity: Name: NameFull: Coussens NP – PersonEntity: Name: NameFull: Simeonov A – PersonEntity: Name: NameFull: Garcia BA – PersonEntity: Name: NameFull: Dibble CC – PersonEntity: Name: NameFull: Meier JL IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 05 Text: 2023 May 16 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |